Our data suggests that rather than targeting IRF1 to reduce overall abundance – which would impede its tumour suppressive function, GSK3β-Fbxw7α aid in the timely clearance of DNA-bound IRF1 to support additional rounds of transcription and thus downstream phenotypes such as reduced proliferation. The gene discussed is IRF1; the disease is neoplasm.